Anselamimab, CAS [[2414866-63-8]]

Produktübersicht

• Artikelname: Anselamimab, CAS [[2414866-63-8]]
• Artikelnummer: TGM-T83106
• Hersteller Artikelnummer: T83106
• Alternativnummer: TGM-T83106-1MG,TGM-T83106-5MG,TGM-T83106-10MG,TGM-T83106-25MG,TGM-T83106-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: CAEL101 , CAEL-101

Produktbeschreibung

Anselamimab is a humanized IgG1kappa monoclonal antibody targeting serum amyloid A1 (SAA1). It removes amyloid deposits by specifically binding to amyloid fibrils and triggering phagocytosis by macrophages and neutrophils.Anselamimab was used as an APP(beta-amyloid A4 Protein Precursor ) inhibitor in the clinical phase for the treatment of light chain (AL) amyloidosis.

Produkteigenschaften

• Reinheit: 98.00%
• CAS Nummer: [2414866-63-8]
• Target-Kategorie: Apolipoprotein|||Beta Amyloid